The substantial guidance raise for Adjusted EBITDA (nearly doubling the midpoint) signals sustained margin improvement and operational leverage. Monitor Q4 2026 results for continued MSER improvement and membership stabilization.
How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 5 $113.77entry
- T+1 · 11d ago −0.33%α −0.65% · $113.39
- T+5 · 5d ago −3.05%α −6.34% · $110.30
- T+7 · todayOpen
- T+20 · in 17d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
agilon health reported Q3 2026 revenue of $1.52B (+6% YoY) and net income of $35M vs a net loss of $110M a year ago, driven by improved medical services expense ratio (88.5% vs 104.0%). The company raised full-year 2026 Adjusted EBITDA guidance to $145M-$155M from $75M-$95M, reflecting strong operational execution and favorable claims development.
Key Financial Metrics
Key Facts
- Q3 2026 total revenue $1.52B, +6% YoY from $1.44B
- Net income $35M vs net loss of $110M in Q3 2025
- Adjusted EBITDA $64M vs negative $91M in Q3 2025
- Medical services expense ratio improved to 88.5% from 104.0%
- Full-year 2026 Adjusted EBITDA guidance raised to $145M-$155M from $75M-$95M
- Full-year 2026 total revenue guidance raised to $5.87B-$5.89B from $5.775B-$5.86B
- Total members on platform decreased 8% YoY to 566,000
Financial Impact
Q3 revenue $1.52B, net income $35M, Adjusted EBITDA $64M; full-year guidance raised significantly
Risk Factors
- Membership continues to decline (down 8% YoY) due to market exits and disciplined contracting
- Favorable claims development in H1 2026 may not repeat
- Stock-based compensation increased to $18.9M in Q3 from $7.5M a year ago
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-070132 |
| Document: agl-20261104.htm | 0001628280-26-070132 |
| Document: 0001628280-26-070132-index-headers.html | 0001628280-26-070132 |
| Document: 0001628280-26-070132-index.html | 0001628280-26-070132 |
| Document: 0001628280-26-070132.txt | 0001628280-26-070132 |
| 8-K Data (Synthetic) | 0001628280-26-070132 |
Track record
7 reports on AGL
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today Institutional Cluster Mixed 3/10 Entry $117.09 Now $116.75 −0.29% settles Nov 23
- Nov 10, 20266d ago Institutional Cluster Neutral 3/10 Entry $113.52 Now $116.75 +2.85% settles Nov 17
- Nov 4, 202612d ago 8-K Bullish 7/10 Viewing Entry $113.77 to $110.30 Now $116.75 +2.62% ▼ −3.05% −6.34% vs SPY
- Apr 27, 202629w ago DEFA14A Neutral 2/10 Entry $27.90 to $26.94 Now $116.75 +318.46% ▼ −3.44% −5.13% vs SPY
- Apr 27, 202629w ago 8-K Neutral 4/10 Entry $27.90 to $26.94 Now $116.75 +318.46% ▼ −3.44% −5.13% vs SPY
- Feb 28, 202637w ago Institutional Cluster Bullish 6/10 Entry $15.40 to $15.00 Now $116.75 +658.12% ▼ −2.60% −1.42% vs SPY
- Feb 25, 202637w ago 8-K Mixed 6/10 Entry $0.5946 to $0.6645 Now $116.75 +19535.05% ▲ +11.76% +12.91% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers